interview
interview
How eXoZymes started: Interviews with Tyler...
Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how...
investors
Looking at the rest of 2025 - part 4 of a...
In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...
investors
Go To Market Strategy - part 3 of a fireside...
In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...
investors
Using AI for Enzyme Engineering - part 2 of a...
In this video - recorded on Dec 29, 2024 - MDB Capital Group’s Lou Basenese interviews Invizyne...
investors
Looking back at 2024 - part 1 of a fireside...
In this video - recorded on Dec 29, 2024 - Lou Basenese interviews Michael Heltzen about going...
interview
Invizyne awarded $250K voucher from DoE
CEO of Invizyne, Michael Heltzen, states, “As a part of our journey from developing brand new...
interview
NREL (DoE): What Invizyne is working on is a...
Yannick Bomble, PhD, Group Research Manager III-Biological Science at NREL (DoE), states: "What...
interview
Interview: NREL (DoE) working with Invizyne
NREL (DoE) working with Invizyne in their 'Advancing Clean Tech to Energize the Future' project -...
investors
Commercializing Invizyne’s cell-free platform -...
Commercializing Invizyne’s cell-free platform - fireside chat withZachary Karl, PhD, Vice...
investors
Invizyne IPO - KOL Call with Dr. James J....
MDB Capital President and Chief Market Strategist Lou Basenese talks with Dr. James J. Lalonde, a...